Families with mutations in TNFRSF13B
Family . | Individual . | Age, y . | Affection status . | TNFRSF13B mutation . | IgG, g/L . | IgA, g/L . | IgM, g/L . |
---|---|---|---|---|---|---|---|
A | I.1 | 42 | Healthy | C104R | 12.9 | 0.83 | 1.24 |
I.2 | 40 | Healthy | C104Y | 12.04 | 1.6 | 0.82 | |
II.1 | 14 | CVID | C104R/C104Y | 2.87 | 0.06 | 0.14 | |
II.2 | 4 | CVID | C104R/C104Y | 3.59 | 0.12 | 0.19 | |
B | I.1 | 55 | Dysgamma | I87N* | 5.5 | 0.36 | 0.99 |
I.2 | 54 | Healthy | Y79C | 7.6 | 1.4 | 1.3 | |
II.1 | 33 | IgG subclass deficiency | Y79C/I87N | 5.9 | 1.1 | 1.3 | |
II.2 | 32 | IgG subclass deficiency | Y79C/I87N | 5.6 | 0.9 | 0.5 | |
C | II.1 | 53 | CVID | c.204insA/C104R | 2.30 | 0.23 | 0.31 |
III.1 | 37 | IgG1 subclass deficiency | c.204insA | 5.94 | 0.69 | 1.31 | |
D | I.2 | 66 | CVID | C104R | 3.31 | 0.07 | 1.18 |
II.1 | 36 | Dysgamma | C104R | 7.14 | 0.34 | 0.64 | |
II.2 | 32 | CVID | C104R | 3.4 | 0 | 0.23 | |
III.1 | 6 | Healthy | wt | 7.43 | 0.58 | 0.36 | |
III.2 | 4 | Dysgamma | wt | 5.53 | 0.24 | 0.53 | |
E(cv78) | I.1 | 87 | SIgAD | unknown | 16.0 | 0 | 3.6 |
I.2 | 77 | Healthy | wt | 12.0 | 1.05 | 0.7 | |
II.1 | 52 | CVID | wt | 8.8† | 0.1 | 0.1 | |
II.2 | 57 | CVID | C104R | 7.4† | 0.1 | 0.1 | |
II.3 | 56 | SIgAD | wt | 16.0 | 0 | 1.6 | |
II.4 | 54 | SIgAD | wt | 15.0 | 0 | 1.6 | |
F(cv132) | I.1 | 61 | Healthy | A181E | NA | NA | NA |
I.2 | 56 | CVID | wt | 9.2† | 0.1 | < 0.1 | |
II.1 | 19 | CVID | A181E | 2.73 | 0.17 | 0.25 | |
II.2 | 26 | Healthy | A181E | 7.8 | 2.0 | 0.9 | |
G | I.1 | 34 | Healthy | wt | 9.78 | 4.86 | 0.81 |
I.2 | 32 | Healthy | D41H;c.298insT | 14.92 | 3.23 | 2.11 | |
II.1 | 9 | CVID | D41H;c.298insT | 0.19 | 0.02 | 3.51 | |
II.2 | 1 | Healthy | D41H;c.298insT | 8.98 | 0.62 | 0.71 |
Family . | Individual . | Age, y . | Affection status . | TNFRSF13B mutation . | IgG, g/L . | IgA, g/L . | IgM, g/L . |
---|---|---|---|---|---|---|---|
A | I.1 | 42 | Healthy | C104R | 12.9 | 0.83 | 1.24 |
I.2 | 40 | Healthy | C104Y | 12.04 | 1.6 | 0.82 | |
II.1 | 14 | CVID | C104R/C104Y | 2.87 | 0.06 | 0.14 | |
II.2 | 4 | CVID | C104R/C104Y | 3.59 | 0.12 | 0.19 | |
B | I.1 | 55 | Dysgamma | I87N* | 5.5 | 0.36 | 0.99 |
I.2 | 54 | Healthy | Y79C | 7.6 | 1.4 | 1.3 | |
II.1 | 33 | IgG subclass deficiency | Y79C/I87N | 5.9 | 1.1 | 1.3 | |
II.2 | 32 | IgG subclass deficiency | Y79C/I87N | 5.6 | 0.9 | 0.5 | |
C | II.1 | 53 | CVID | c.204insA/C104R | 2.30 | 0.23 | 0.31 |
III.1 | 37 | IgG1 subclass deficiency | c.204insA | 5.94 | 0.69 | 1.31 | |
D | I.2 | 66 | CVID | C104R | 3.31 | 0.07 | 1.18 |
II.1 | 36 | Dysgamma | C104R | 7.14 | 0.34 | 0.64 | |
II.2 | 32 | CVID | C104R | 3.4 | 0 | 0.23 | |
III.1 | 6 | Healthy | wt | 7.43 | 0.58 | 0.36 | |
III.2 | 4 | Dysgamma | wt | 5.53 | 0.24 | 0.53 | |
E(cv78) | I.1 | 87 | SIgAD | unknown | 16.0 | 0 | 3.6 |
I.2 | 77 | Healthy | wt | 12.0 | 1.05 | 0.7 | |
II.1 | 52 | CVID | wt | 8.8† | 0.1 | 0.1 | |
II.2 | 57 | CVID | C104R | 7.4† | 0.1 | 0.1 | |
II.3 | 56 | SIgAD | wt | 16.0 | 0 | 1.6 | |
II.4 | 54 | SIgAD | wt | 15.0 | 0 | 1.6 | |
F(cv132) | I.1 | 61 | Healthy | A181E | NA | NA | NA |
I.2 | 56 | CVID | wt | 9.2† | 0.1 | < 0.1 | |
II.1 | 19 | CVID | A181E | 2.73 | 0.17 | 0.25 | |
II.2 | 26 | Healthy | A181E | 7.8 | 2.0 | 0.9 | |
G | I.1 | 34 | Healthy | wt | 9.78 | 4.86 | 0.81 |
I.2 | 32 | Healthy | D41H;c.298insT | 14.92 | 3.23 | 2.11 | |
II.1 | 9 | CVID | D41H;c.298insT | 0.19 | 0.02 | 3.51 | |
II.2 | 1 | Healthy | D41H;c.298insT | 8.98 | 0.62 | 0.71 |
Patients and relatives were assigned to their respective affection status as being healthy, or having sIgAD, dysgamma, IgG subclass deficiency, or CVID.
Values below normal range for age are printed in italics. Dysgamma indicates dysgammaglobulinemia; wt, wild type; and NA, not available.
This mutation was inferred.
IgG level while the patient received intravenous immunoglobulin substitution therapy.